GlassScriptPhysician profile
Iswanto Sucandy
NPI 1396903696
$102,664.66
in general payments reported to CMS, 2019-2025
37 companies · $34K in 2025
The $34K reported for 2025 was more than what 98% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,197 · 2020: $97.75 · 2021: $4,476 · 2022: $17K · 2023: $12K · 2024: $32K · 2025: $34K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $30K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $26K · Travel and Lodging: $11K · Food and Beverage: $5,759 · Consulting Fee: $4,102 · Honoraria: $520 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $30,400.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $26,250.00 |
| Travel and Lodging | $10,530.56 |
| Food and Beverage | $5,758.59 |
| Consulting Fee | $4,102.29 |
| Honoraria | $520.00 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $88,820.92 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Baxter Healthcare | $4,187.33 | 2019-2024 | Tisseel |
| Fujifilm Corporation | $3,419.00 | 2025 | Synapse 3d |
| Pfizer INC. | $1,400.00 | 2021 | |
| Medicaroid, INC. | $683.29 | 2024 | |
| Becton, Dickinson and Company | $520.00 | 2025 | |
| Lexington Medical, INC. | $506.18 | 2024 | Aeon Endostapler & Echelon Flex Powered Stapler |
| Ethicon INC. | $505.00 | 2022 | |
| Medtronic, INC. | $454.69 | 2022-2024 | Signia |
| Ethicon US, LLC | $302.19 | 2019-2024 | Ethicon, Evarrest, Vistaseal |
| W. L. Gore & Associates, INC. | $217.97 | 2019-2024 | Gore Seamguard Bioabsorbable Staple Line Reinforce |
| Angiodynamics, INC. | $169.31 | 2021-2023 | Solero |
| Fujifilm Healthcare Americas Corporation | $162.42 | 2023 | Synapse 3d, Arietta Precision |
| Histosonics, INC. | $150.00 | 2025 | |
| Intera Oncology, INC | $133.56 | 2025 | Intera |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $112.18 | 2019 | |
| Covidien LP | $110.94 | 2019 | |
| Ambu INC. | $108.65 | 2022 | |
| Boston Scientific Corporation | $93.67 | 2023 | |
| Lucid Diagnostics INC. | $89.28 | 2021-2023 | |
| Olympus America INC. | $67.13 | 2019 | |
| Stryker Corporation | $64.50 | 2021 | |
| Medical Device Business Services, INC. | $58.05 | 2024 | Echelon Flex |
| Tela Bio, INC. | $54.95 | 2022-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Portola Pharmaceuticals, LLC | $39.06 | 2020 | |
| Abbvie INC. | $36.10 | 2022 | |
| Ets Wound Care LLC | $33.14 | 2025 | Mirragen Advanced Wound Matrix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.97 | 2019 | |
| Integra Lifesciences Corporation | $22.54 | 2019 | |
| Nestle Healthcare Nutrition INC. | $18.52 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.64 | 2020 | |
| Next Science LLC | $17.63 | 2019 | |
| Trevena, INC. | $16.68 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $13.24 | 2021 | |
| Smith+Nephew, INC. | $12.70 | 2022 | |
| Alcresta Therapeutics, INC. | $12.00 | 2019 | |
| Bolder Surgical LLC | $11.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Iswanto Sucandy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.